Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02875353 · ClinicalTrials.gov registry record · NA
Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding
A NA study of Delayed Post-Polypectomy Induced Ulcer Hemorrhage, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 3
- Study locations
NCT02875353 is a NA study of Delayed Post-Polypectomy Induced Ulcer Hemorrhage that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 180 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT02875353, a NA study of Delayed Post-Polypectomy Induced Ulcer Hemorrhage, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary specific aim is to perform a randomized controlled trial (RCT) to compare rates of delayed hemorrhage after DEP detection of arterial blood flow and focal treatment in PPIU's (treatment arm) with standard treatment using medical guidelines alone (controls) for prevention of delayed bleeding in high risk patients (on anti-coagulants or anti-platelet drugs or with large ulcers) after snare resection of benign colon polyps.
Conditions Studied
Interventions
- DEVICE Doppler Endoscopic Probe
Study Locations (3)
California
- Kaiser Permanente-Downey Medical Center - Downey
- University of California, Los Angeles, Ronald Reagan Medical Center - Los Angeles
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2026-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02875353
The ClinicalTrials.gov registry entry for NCT02875353 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Delayed Post-Polypectomy Induced Ulcer Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Doppler Endoscopic Probe is the first listed.
NCT02875353 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02875353 about?
NCT02875353 is a clinical study titled "Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding". The primary specific aim is to perform a randomized controlled trial (RCT) to compare rates of delayed hemorrhage after DEP detection of arterial blood flow and focal treatment in PPIU's (treatment arm) with standard treatment using medical guidelines alone (controls) for prevention of delayed bleed...
What is the current status of trial NCT02875353?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2017-02-15. Estimated completion is 2026-05-29.
What conditions does trial NCT02875353 study?
This clinical trial studies the following conditions: Delayed Post-Polypectomy Induced Ulcer Hemorrhage.
What interventions are being tested in trial NCT02875353?
The interventions under investigation include: Doppler Endoscopic Probe (DEVICE).
Who is sponsoring clinical trial NCT02875353?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02875353 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.